Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Neuroradiology
|
July 27, 2007
Recombinant factor VIIa (rFVIIa): its potential role as a hemostatic agent
Ulla Hedner, Nikolai C Brun
Expert Opinion on Drug Safety
|
March 4, 2020
Advanced analytics - translating registry science into regulatory actions
Kåre Kemp, Nikolai C Brun, Jens P Quartarolo
Clinical Pharmacology and Therapeutics
|
December 18, 2019
Big Data - How to Realize the Promise
Alison Cave, Nikolai C Brun, Fergus Sweeney, et al.
Stroke
|
December 1, 2004
Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage
Stephan A Mayer, Nikolai C Brun, Joseph Broderick, et al.
Stroke
|
May 24, 2008
Timing is everything in intracerebral hemorrhage
Thorsten Steiner, Joseph Broderick, Nikolai C Brun, et al.
Neurocritical Care
|
June 8, 2006
Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial
Stephan A Mayer, Nikolai C Brun, Joseph Broderick, et al.
Stroke
|
February 2, 2008
Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage
Michael N Diringer, Brett E Skolnick, Stephan A Mayer, et al.
The New England Journal of Medicine
|
February 25, 2005
Recombinant activated factor VII for acute intracerebral hemorrhage
Stephan A Mayer, Nikolai C Brun, Kamilla Begtrup, et al.
Stroke
|
December 5, 2009
Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial
Michael N Diringer, Brett E Skolnick, Stephan A Mayer, et al.
The New England Journal of Medicine
|
May 16, 2008
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage
Stephan A Mayer, Nikolai C Brun, Kamilla Begtrup, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Neuroradiology
|
July 27, 2007
Recombinant factor VIIa (rFVIIa): its potential role as a hemostatic agent
Ulla Hedner, Nikolai C Brun
Expert Opinion on Drug Safety
|
March 4, 2020
Advanced analytics - translating registry science into regulatory actions
Kåre Kemp, Nikolai C Brun, Jens P Quartarolo
Clinical Pharmacology and Therapeutics
|
December 18, 2019
Big Data - How to Realize the Promise
Alison Cave, Nikolai C Brun, Fergus Sweeney, et al.
Stroke
|
December 1, 2004
Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage
Stephan A Mayer, Nikolai C Brun, Joseph Broderick, et al.
Stroke
|
May 24, 2008
Timing is everything in intracerebral hemorrhage
Thorsten Steiner, Joseph Broderick, Nikolai C Brun, et al.
Neurocritical Care
|
June 8, 2006
Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial
Stephan A Mayer, Nikolai C Brun, Joseph Broderick, et al.
Stroke
|
February 2, 2008
Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage
Michael N Diringer, Brett E Skolnick, Stephan A Mayer, et al.
The New England Journal of Medicine
|
February 25, 2005
Recombinant activated factor VII for acute intracerebral hemorrhage
Stephan A Mayer, Nikolai C Brun, Kamilla Begtrup, et al.
Stroke
|
December 5, 2009
Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial
Michael N Diringer, Brett E Skolnick, Stephan A Mayer, et al.
The New England Journal of Medicine
|
May 16, 2008
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage
Stephan A Mayer, Nikolai C Brun, Kamilla Begtrup, et al.
Page
of 2